Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Trusheim

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Managed Care & Specialty Pharmacy|April 29, 2025
Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenuesColin M Young, Sharon E Phares, Annie Kennedy, et al.
Nature Reviews. Drug Discovery|November 30, 2013
Market watch: defining and quantifying the use of personalized medicinesSean X Hu, Murray L Aitken, Arnold M Epstein, et al.
The Israel Medical Association Journal : IMAJ|November 26, 2013
Personalized medicine and health economics: is small the new big? A white paperIfat Abadi-Korek, Jacob Glazer, Alicia Granados, et al.
Health Affairs (Project Hope)|June 7, 2021
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And UsersAriel Dora Stern, Jacqueline L Chen, Melissa Ouellet, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.
The AAPS Journal|March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop ReportSophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Managed Care & Specialty Pharmacy|April 29, 2025
Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenuesColin M Young, Sharon E Phares, Annie Kennedy, et al.
Nature Reviews. Drug Discovery|November 30, 2013
Market watch: defining and quantifying the use of personalized medicinesSean X Hu, Murray L Aitken, Arnold M Epstein, et al.
The Israel Medical Association Journal : IMAJ|November 26, 2013
Personalized medicine and health economics: is small the new big? A white paperIfat Abadi-Korek, Jacob Glazer, Alicia Granados, et al.
Health Affairs (Project Hope)|June 7, 2021
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And UsersAriel Dora Stern, Jacqueline L Chen, Melissa Ouellet, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.
The AAPS Journal|March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop ReportSophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
Pageof 2